What is the current state of research on long-term therapy using PARP inhibitors in patients with BRCA mutations?
Hassan GHAZAL
oncologist, Dubai
oncologist, Dubai
New User? Click here to register
Text generated by AI based on an exclusive interview, revised and reviewed by
Yazid BELKACEMI
Chairman of the Radiation Oncology Department and the Henri-Mondor Breast Center, Henri- Mondor University Hospital, Créteil, France
Dalila AHNOU
Luc Rotenberg
Neuilly sur Seine, France
Expert Opinions Dubai 2022
Breast Cancer Update
Didier Bourgeois
Chirurgien cancérologue spécialisé en sénologie et gynécologie
à l’Institut du Sein Henri Hartmann, Neuilly Sur Seine, France
Copyright © 2026 - BCU